Injectable treatment is the volume business of London aesthetics. It is also the part of the market where the gap between what patients assume about regulation and what regulation actually does is widest. This guide sets out how the two main injectable categories are governed in the United Kingdom, what they cost across the six districts covered by this guide, and which questions actually change the risk you are taking.
Two categories that are regulated completely differently
Almost everything patients find confusing about injectables comes from treating them as one category. They are not.
Botulinum toxin is a prescription-only medicine. Products containing it are licensed by the Medicines and Healthcare products Regulatory Agency, and a prescription may only be issued by an appropriate prescriber, which in practice means a doctor, a dentist, or a nurse or pharmacist with prescribing qualifications. Professional guidance is clear that the prescriber should assess the patient in person before prescribing, and that remote prescribing for cosmetic injectables is not acceptable. Advertising prescription-only medicines to the public is also restricted, which is why compliant clinics discuss the treatment area rather than promoting a brand name.
Dermal fillers in the United Kingdom are regulated as medical devices rather than as medicines. There is no prescription requirement, and in law there is no restriction on who may inject them into an adult, beyond the general duties that apply to any commercial service. That is the reality patients most often find surprising, and it is the reason the practitioner registers do so much of the work that regulation does not.
Two protections do exist and are worth knowing. It is a criminal offence to administer botulinum toxin or a subcutaneous, submucous or intradermal filler for cosmetic purposes to a person under eighteen in England, other than under a doctor's direction. And clinics carrying out regulated activity in England must register with the Care Quality Commission, though much routine non-surgical injectable work sits outside that definition.
What you are actually buying
The price of an injectable treatment covers four things, and clinics differ in how much of each they include.
- The product. Toxin is priced per unit or per area; filler is priced per millilitre or per syringe. Product families differ in cross-linking, longevity and how they behave in tissue, and the difference between the cheapest and the most expensive product in a London clinic can be several hundred pounds per millilitre.
- The assessment. A proper first assessment covers medical history, medication, previous treatment, anatomy, expectations and contraindications, and includes the possibility that the answer is no.
- The practitioner's time and skill. Injectable outcomes are technique dependent to a degree that patients consistently underestimate. Product choice matters far less than placement.
- The safety net. Review appointments, access to the practitioner afterwards, emergency drugs on site, and a documented plan if something goes wrong. This is the component most often missing from the cheapest prices.
London price bands by district
Indicative 2026 ranges, drawn from the six districts covered in this guide. They describe the market, not any individual practice.
| District | Toxin, one area | Toxin, three areas | Filler, per ml |
|---|---|---|---|
| Marylebone | £250 to £450 | £400 to £750 | £450 to £950 |
| Kensington | £250 to £450 | £400 to £700 | £450 to £900 |
| The City | £220 to £400 | £350 to £600 | £400 to £750 |
| Chiswick | £180 to £320 | £300 to £520 | £350 to £700 |
| Wimbledon | £170 to £320 | £280 to £520 | £320 to £700 |
| Shoreditch | £150 to £300 | £250 to £450 | £280 to £600 |
The spread across the city for the same nominal treatment is roughly three to one. Some of that is rent. Some is practitioner seniority. Some is product. And some is the safety net described above, which is invisible at the point of sale and only becomes visible when you need it.
Below roughly £250 per millilitre of filler in London, something in the chain is being economised. You are entitled to know what.
What the common treatment areas involve
Botulinum toxin
The three areas most commonly treated are the frown lines between the brows, the horizontal forehead lines and the lines at the outer corners of the eyes. Onset is gradual over three to fourteen days, and the effect typically lasts three to four months before muscle activity returns. Repeat treatment at intervals shorter than twelve weeks is not usually recommended. Common temporary effects include small raised marks at the injection points, bruising and headache. The effects that concern patients most, such as a heavy brow or a drooping eyelid, are placement related, temporary and uncommon in experienced hands.
Dermal filler
Most filler used in London is hyaluronic acid based, which matters because it can be broken down with an enzyme, hyaluronidase, if a correction or an emergency reversal is needed. Common areas include the cheeks, the nasolabial folds, the chin and jawline, and the lips. The under-eye area, often called the tear trough, is technically the most demanding and the one where poor placement is most visible and most persistent.
The complication that matters is vascular occlusion, where filler compromises the blood supply to an area of tissue. It is rare, it is a medical emergency, and it is time critical. Every practitioner offering filler should hold hyaluronidase on site, should be trained to recognise occlusion, and should be able to tell you their protocol without hesitating. If they cannot, that is the end of the conversation.
The checks that actually change your risk
- Verify the individual. Doctors on the GMC register, nurses and midwives on the NMC register. Both are public, searchable and free. Practitioners meeting published training and premises standards also appear on the JCCP register and the Save Face register.
- Confirm the prescriber. For any prescription-only medicine, ask who prescribes and whether they have assessed you face to face. If the answer involves someone you have never met, decline.
- See the product. Ask for the name and to see the packaging before it is used. A practitioner with nothing to hide will show you without being asked twice.
- Establish the emergency route. What drugs are on site, what is the vascular occlusion protocol, who answers out of hours.
- Insist on a gap. Assessment and treatment on the same day is normal in London. A cooling-off period is still your right to request, and any practice that resists giving you one is telling you what it optimises for.
Choosing by district rather than by price
If your case is straightforward and you have been treated safely before, the district you choose should be the one that makes review appointments easy to attend, because follow-up is the part people skip when it is inconvenient. If your case involves correcting previous work, a complicated medical history or a decision about surgery, the consultant density of Marylebone is a genuine advantage. If you want a long relationship with one practitioner at a fair price, Chiswick and Wimbledon Village are built for exactly that. If price is the binding constraint, Shoreditch offers the widest choice in London and demands the most verification in return.